<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">Rodent models</z:e> of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> have been extremely useful in elucidating pathomechanisms of human <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Most commonly, a monofilament is advanced through the internal carotid artery of rodents to occlude the origin of the middle cerebral artery thus leading to critical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the corresponding vascular territory </plain></SENT>
<SENT sid="2" pm="."><plain>The filament can be removed after different occlusion times allowing reperfusion (transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model) or is left permanently within the internal carotid artery (permanent MCAO model) both mimicking clinical <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> in which the occluding clot may resolve spontaneously or after thrombolysis, or may persist </plain></SENT>
<SENT sid="3" pm="."><plain>Overall, the occlusion time determines the extent of ischemic brain damage, but <z:mpath ids='MPATH_124'>infarcts</z:mpath> still grow during reperfusion, a process involving complex interactions between platelets, endothelial cells, immune cells, and the coagulation system </plain></SENT>
</text></document>